Breast Cancer Incidence in Black and White Women Stratified by Estrogen and Progesterone Receptor Statuses

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Gleason, Michael X ^a   Mdzinarishvili, Tengiz ^a   Sherman, Simon ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CAUCASIAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PHENOTYPE; RACE DIFFERENCE; RISK ASSESSMENT;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; PHENOTYPE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84869132782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049359     Document Type: Article

References (53)

1. American Cancer Society (2010) Cancer Facts & Figures 2010. Atlanta: American Cancer Society. 62 p. Available: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2010-rev. Accessed 2010 Sep 29.
2. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, et al. (1970) Age at first birth and breast cancer risk. Bulletin of the World Health Organization 43: 209-221.
3. Trichopoulos D, Hsieh C-C, MacMahon B, Lln T-M, Lowe CR, et al. (1983) Age at any birth and breast cancer risk. Int J Cancer 31: 701-704 doi:10.1002/ijc.2910310604.
4. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713-1727.
5. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059.
6. Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, et al. (2009) Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101: 296-305 doi:10.1093/jnci/djn514.
7. Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360: 187-195 doi:10.1016/S0140-6736(02)09454-0.
8. Wiseman M, (2008) The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 67: 253-256 doi:10.1017/S002966510800712X.
9. Armitage P, Doll R, (1954) The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8: 1-12.
10. Pompei F, Wilson R, (2001) Age distribution of cancer: the incidence turnover at old age. Hum Ecol Risk Assess 7: 1619-1650.
11. Cook PJ, Doll R, Fellingham SA, (1969) A mathematical model for the age distribution of cancer in man. Int J Cancer 4: 93-112.
12. Moolgavkar SH, Knudson AG Jr, (1981) Mutation and cancer: A model for human carcinogenesis. J Natl Cancer Inst 66: 1037.
13. Luebeck EG, Moolgavkar SH, (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A 99: 15095.
14. Clemmesen J, (1948) Carcinoma of the breast; results from statistical research. Br J Radiol 21: 583-590.
15. Clemmesen J, (1951) On the etiology of some human cancers. J Natl Cancer Inst 12: 1-24.
16. Anderson E, Reed SC, Huseby RA, Oliver CP, (1950) Possible relationship between menopause and age at onset of breast cancer. Cancer 3: 410-414.
17. Lilienfeld AM, Johnson EA, (1955) The age distribution in female breast and genital cancers. Cancer 8: 875-882.
18. De Waard F, De Laive JWJ, Baanders-van Halewijn EA, (1960) On the bimodal age distribution of mammary carcinoma. Br J Cancer 14: 437-448.
19. Manton KG, Stallard E, (1980) A two-disease model of female breast cancer: mortality in 1969 among white females in the United States. J Natl Cancer Inst 64: 9-16.
20. Anderson WF, Matsuno R, (2006) Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 98: 948-951.
21. Turnbull L, Brown S, Harvey I, Olivier C, Drew P, et al. (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375: 563-571.
22. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, et al. (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362: 513-520.
23. Holli K, Hietanen P, Saaristo R, Huhtala H, Hakama M, et al. (2009) Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. J Clin Oncol 27: 927-932.
24. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, et al. (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87: 1622-1629.
25. Gray GE, Henderson BE, Pike MC, (1980) Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst 64: 461-463.
26. Hankey BF, Miller B, Curtis R, Kosary C, (1994) Trends in breast cancer in younger women in contrast to older women. JNCI Monographs 16: 7-14.
27. Velentgas P, Daling JR, (1994) Risk factors for breast cancer in younger women. JNCI Monographs pp. 15-24.
28. Brinton LA, Benichou J, Gammon MD, Brogan DR, Coates R, et al. (1997) Ethnicity and variation in breast cancer incidence. Int J Cancer 73: 349-355.
29. Pathak DR, Osuch JR, He J, (2000) Breast carcinoma etiology. Cancer 88: 1230-1238.
30. Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM, (2008) Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 100: 1804-1814.
31. Stevens RG, Moolgavkar SH, Lee JAH, (1982) Temporal trends in breast cancer. Am J Epidemiol 115: 759-777.
32. Parkin DM, Bray FI, Devesa SS, (2001) Cancer burden in the year 2000. The global picture (suppl 8). Eur J Cancer 37: 4-66.
33. Colditz GA, Rosner B, (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 152: 950-964.
34. Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L, (2003) Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 95: 478-483.
35. Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, et al. (2003) Breast cancer genetics in African Americans. Cancer 97: 236-245.
36. Forshee RA, Storey ML, Ritenbaugh C, (2003) Breast cancer risk and lifestyle differences among premenopausal and postmenopausal African-American women and white women. Cancer 97: 280-288.
37. Newman LA, (2005) Breast cancer in African-American women. The Oncologist 10: 1-14.
38. Knight WA, Livingston RB, Gregory EJ, McGuire WL, (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669.
39. Horwitz KB, McGuire WL, (1978) Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 253: 2223.
40. Richard J, Sainsbury C, Needham GK, Farndon JR, Malcolm AJ, et al. (1987) Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 329: 1398-1402.
41. Surveillance, Epidemiology, and End Results (SEER) Program Limited-Use Data (1973-2008) (2011) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. (www.seer.cancer.gov).
42. Ettinger B, Grady D, Tosteson A, Pressman A, Macer J, (2003) Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 102: 1225.
43. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333.
44. Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, et al. (2007) SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute. 286 p. Available: http://seer.cancer.gov/publications/survival/seer_survival_mono_highres.pdf. Accessed 2010 Sep 29.
45. Surveillance, Epidemiology, and End Results (SEER) Program (2008) Rate Algorithms. Available: http://seer.cancer.gov/seerstat/WebHelp/Rate_Algorithms.htm. Accessed 2011 Nov 28.
46. Surveillance, Epidemiology, and End Results (SEER) Program (2008) Standard Populations (Millions) for Age-Adjustment. Available: http://seer.cancer.gov/stdpopulations/stdpop.singleagesthru99.txt. Accessed 2011 Nov 28.
47. Mdzinarishvili T, Sherman S, (2012) A Heuristic Solution of the Identifiability Problem of the Age-Period-Cohort Analysis of Cancer Occurrence: Lung Cancer Example. PLoS ONE 7: e34362 doi:10.1371/journal.pone.0034362.
48. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752 doi:10.1038/35021093.
49. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
50. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352 doi:10.1038/nature10983.
51. De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, et al. (2008) Does Estrogen Receptor-Negative/Progesterone Receptor-Positive Breast Carcinoma Exist? J Clin Oncol 26: 335-336 doi:10.1200/JCO.2007.14.8411.
52. Kravchenko J, Akushevich I, Seewaldt VL, Abernethy AP, Lyerly HK, (2011) Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms. Breast Cancer Res Tr 128: 483-493.
53. Weigel M, Dowsett M, (2010) Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr-Relat Cancer 17: R245-R262.